Sensitivity of Non-Invasive Prenatal Testing (NIPT)
Overall Performance for Common Trisomies
NIPT demonstrates exceptionally high sensitivity for detecting fetal chromosomal abnormalities, with 99.3% sensitivity for trisomy 21 (Down syndrome), 97.4% for trisomy 18 (Edwards syndrome), and 97.4% for trisomy 13 (Patau syndrome) in singleton pregnancies. 1
Trisomy 21 (Down Syndrome)
- Sensitivity: 98.8-99.3% with a false-positive rate of only 0.04% 2, 1
- This represents a detection rate superior to all traditional screening methods 3
- Specificity reaches 99.9% across multiple studies 1
Trisomy 18 (Edwards Syndrome)
- Sensitivity: 97.4-98.83% with a false-positive rate of 0.07% 2, 1
- In twin pregnancies, sensitivity decreases to 90% (95% CI = 67.6%-97.5%) with specificity of 99.95% 3, 4
Trisomy 13 (Patau Syndrome)
- Sensitivity: 92.85-97.4% with a false-positive rate of 0.04% 2, 1
- In twin pregnancies, sensitivity drops to 80% (95% CI = 30.9%-97.3%) with specificity of 99.93% 3, 4
Sex Chromosome Aneuploidies
NIPT shows an overall detection rate of 99.6% (95% CI = 94.8%-100%) for sex chromosome aneuploidies with 99.8% specificity. 3, 2
However, positive predictive values vary significantly by condition:
- Monosomy X (Turner syndrome): 29.5% PPV (95% CI = 22.7%-37.4%) 3, 2
- Triple X syndrome (47,XXX): 54% PPV (95% CI = 40.6%-66.8%) 3, 2
- Klinefelter syndrome (47,XXY): 74% PPV (95% CI = 59.5%-84.7%) 3, 2
- 47,XYY syndrome: 74.5% PPV (95% CI = 58.4%-85.8%) 3, 2
The lower PPV for monosomy X reflects higher rates of placental mosaicism and maternal mosaicism that would not be detected through amniocentesis 3
Performance in Twin Pregnancies
NIPT maintains excellent performance in twin gestations, with sensitivity of 98.2% for trisomy 21, though slightly reduced for trisomies 18 and 13. 4, 2
- Trisomy 21: 98.2% sensitivity (95% CI = 88.2%-99.7%) and 99.9% specificity 4
- Trisomy 18: 90% sensitivity (95% CI = 67.6%-97.5%) and 99.95% specificity 4
- Trisomy 13: 80% sensitivity (95% CI = 30.9%-97.3%) and 99.93% specificity 4
This represents a 9% reduction in sensitivity for trisomy 21,28% reduction for trisomy 18, and 22% reduction for trisomy 13 compared to singleton pregnancies 1
Critical Factors Affecting Sensitivity
Test Failure and No-Call Results
- Approximately 1% of samples result in "no-call" results, most commonly due to insufficient fetal fraction 3, 4
- Repeat testing provides results in 75-80% of cases 3
- High maternal BMI increases test failure rates up to 20% due to low fetal fraction 4
Timing Considerations
- NIPT should be performed after 10 weeks gestation when fetal fraction is adequate (10-15% of cell-free DNA is placental origin) 4
- Sensitivity is lower in first trimester testing compared to later gestational ages 1
Absolute Contraindications
- Known vanishing twin or triplet: NIPT should NOT be performed due to risk of false-positive results or test failure 4, 5
- Known maternal malignancy: Relative contraindication due to potential somatic genomic aberrations 4, 2
Comparison to Traditional Screening
NIPT dramatically outperforms traditional screening methods:
- Traditional second trimester biochemistry: 63% detection rate with 10.8% false-positive rate 3, 4
- First trimester NT with biochemistry: 75% detection rate with 9% false-positive rate 3, 4
- NIPT for trisomy 21: 98.8-99.3% detection rate with 0.04% false-positive rate 2
This translates to requiring only 1.1-2 amniocentesis procedures to confirm one case of trisomy 21 with NIPT versus 28-45 procedures with traditional screening 3
Essential Clinical Caveats
- NIPT is a screening test, not diagnostic - all positive results require confirmatory invasive testing with amniocentesis or chorionic villus sampling 4, 6
- False-positive results occur in 0.2-1% of cases, and false-negative results are possible 7
- NIPT cannot replace ultrasound for structural anomaly detection 4
- Some pregnancies with no-call results have higher rates of fetal chromosome disorders, though this association is not universally confirmed 3